Other
Prevention
0
Pipeline Programs↗
62
Active Trials↗
34
Companies Involved↗
Prevention is an early-stage landscape with 0 programs across 34 companies. The most active players are AstraZeneca, MediQuest Therapeutics, GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
463
clinical trials
Completed259 · 56%
Unknown status83 · 18%
Terminated41 · 9%
Recruiting38 · 8%
Withdrawn17 · 4%
Not yet recruiting12 · 3%
Other13 · 3%
Clinical Trials
Trial Activity
463 trials
Rectal NSAIDs With/Without PD Stent for PEP Prevention
Recruiting·—·N/A·NCT07117318·1,278 enrolled
Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
Recruiting·TThe Second Affiliated Hospital of Chongqing Medical University·N/A·NCT06188195·500 enrolled
Page 1 of 31
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)